Mechanisms for reduced pulmonary diffusing capacity in haematopoietic stem-cell transplantation recipients

被引:8
作者
Barisione, Giovanni [1 ]
Bacigalupo, Andrea [1 ]
Brusasco, Claudia [2 ]
Scanarotti, Chiara [3 ]
Penco, Susanna [3 ]
Bassi, Anna Maria [3 ]
Lamparelli, Teresa [1 ]
Garlaschi, Alessandro [1 ]
Pellegrino, Riccardo [4 ]
Brusasco, Vito [2 ]
机构
[1] IRCCS Azienda Osped Univ San Martino IST, I-16132 Genoa, Italy
[2] Univ Genoa, Dipartimento Med Interna & Specialita Med, Genoa, Italy
[3] Univ Genoa, Dipartimento Med Sperimentale, Genoa, Italy
[4] Azienda Osped S Croce & Carle, Cuneo, Italy
关键词
Carbon monoxide; Nitric oxide; Alveolar-capillary membrane conductance; Pulmonary capillary volume; Reactive oxygen metabolites; Lung density; BONE-MARROW-TRANSPLANTATION; HIGH-DOSE CHEMOTHERAPY; IDIOPATHIC PNEUMONIA SYNDROME; SIGNIFICANT BLOOD RESISTANCE; NITRIC-OXIDE TRANSFER; LONG-TERM SURVIVORS; C-REACTIVE PROTEIN; CARBON-MONOXIDE; LUNG-FUNCTION; LYMPHOMA PATIENTS;
D O I
10.1016/j.resp.2014.01.018
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Lung diffusing capacity for CO (DLCO) is compromised in haematopoietic stem-cell transplantation (HSCT) recipients. We derived alveolar-capillary membrane conductance (D-M,D-CO) and pulmonary capillary volume (V-C) from DLCO and diffusing capacity for NO (DLNO). Forty patients were studied before and 6 weeks after HSCT. Before HSCT, DLNO and DLCO were significantly lower than in 30 healthy controls. D-M,D-CO was similar to 40% lower in patients than in controls (p < 0.001), whereas V-C did not differ significantly. After HSCT, DLNO and D-M,D-CO further decreased, the latter by similar to 22% from before HSCT (p < 0.01) while V-C did not change significantly. Lung density, serum CRP and reactive oxygen metabolites were significantly increased, with the latter being correlated (R-2 = 0.71, p < 0.001) with the decrement in DLNO. We conclude that DLNO and, to a lesser extent, DLCO are compromised before HSCT mainly due to a D-M,D-CO reduction. A further reduction of D-M,D-CO without V-C loss occurs after HSCF, possibly related to development of oedema, or interstitial fibrosis, or both. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:54 / 61
页数:8
相关论文
共 50 条
  • [41] Osteonecrosis of the jaw secondary to haematopoietic stem cell transplantation
    Sandhu, Shaiba
    Sankar, Vidya
    BMJ CASE REPORTS, 2021, 14 (03)
  • [42] Haematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease
    Slatter, M. A.
    Gennery, A. R.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (18)
  • [43] Pulmonary Function in Pediatric Stem Cell Transplantation
    Srichaisawat, Panuwat
    Deerojanawong, Jitladda
    Harnruthakorn, Chanthana
    TRANSPLANTATION PROCEEDINGS, 2024, 56 (09) : 2032 - 2038
  • [44] Pulmonary function testing prior to reduced intensity conditioning allogeneic stem cell transplantation in an unselected patient cohort predicts posttransplantation pulmonary complications and outcome
    Luis Pinana, Jose
    Martino, Rodrigo
    Barba, Pere
    Bellido-Casado, Jesus
    Valcarcel, David
    Sureda, Anna
    Briones, Javier
    Brunet, Salut
    Manuel Rodriguez-Arias, Jose
    Casan, Pere
    Sierra, Jorge
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (01) : 9 - 14
  • [45] Reduced Insulin Sensitivity in Childhood Survivors of Haematopoietic Stem Cell Transplantation Is Associated With Lipodystropic and Sarcopenic Phenotypes
    Wei, Christina
    Thyagiarajan, Manigandan S.
    Hunt, Linda P.
    Shield, Julian P. H.
    Stevens, Michael C. G.
    Crowne, Elizabeth C.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (11) : 1992 - 1999
  • [46] Neuroimaging findings of posterior reversible encephalopathy syndrome (PRES) following haematopoietic stem cell transplantation in paediatric recipients
    Atca, Ali Onder
    Erok, Berrin
    Aydogdu, Selime
    BMC PEDIATRICS, 2021, 21 (01)
  • [47] Multiple myeloma and autologous haematopoietic stem-cell transplantation without cryopreservation: experiences of the Clinical Hematology Department of Casablanca, Morocco
    Fares, Salma
    Hadri, Halima
    Rachid, Mohamed
    Moutiqui, Tarik
    Oukkache, Bouchra
    Quessar, Asmaa
    PAN AFRICAN MEDICAL JOURNAL, 2021, 39
  • [48] Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer
    Jenq, Robert R.
    van den Brink, Marcel R. M.
    NATURE REVIEWS CANCER, 2010, 10 (03) : 213 - 221
  • [49] Clinical Significance of Autoantibody Expression in Allogeneic Stem-Cell Recipients
    Moon, Joon-Ho
    Lee, Soo-Jung
    Kim, Jong-Gwang
    Chae, Yee-Soo
    Kim, Shi-Nae
    Kang, Byung-Woog
    Suh, Jang-Soo
    Lee, Kun-Soo
    Sohn, Sang-Kyun
    TRANSPLANTATION, 2009, 88 (02) : 242 - 250
  • [50] Lung histopathology of non-infectious pulmonary complications after allogeneic haematopoietic stem cell transplantation
    Meignin, Veronique
    Thivolet-Bejui, Francoise
    Kambouchner, Marianne
    Hussenet, Claire
    Bondeelle, Louise
    Mitchell, Andrew
    Chagnon, Karine
    Begueret, Hugues
    Segers, Valerie
    Cottin, Vincent
    Tazi, Abdellatif
    Chevret, Sylvie
    Danel, Claire
    Bergeron, Anne
    HISTOPATHOLOGY, 2018, 73 (05) : 832 - 842